MMI SpA announced today that it received CE Mark for and launched its Symani surgical system for open microsurgical procedures.
Calci, Italy-based MMI’s Symani system also experienced its first human use, having been used in four successful robotic surgeries performed in Florence, Italy. Three of those procedures were complex, post-traumatic lower limb reconstructions, with one post-oncological reconstruction of the pharynx, according to a news release.
Symani includes tremor reduction and motion scaling with what MMI touts as the world’s smallest wristed instrumentation, offering seven degrees of freedom and dexterity that outdoes the human hands.
The system’s NanoWrist instruments are designed to perform free-flap reconstructions, replantations, congenital malformations, peripheral nerve repairs and lymphatic surgery, MMI said.
“There is a clear demand for robotics in microsurgery as the limits of the human hand have already been reached,” MMI co-founder & CEO Giuseppe Maria Prisco said in the release. “We founded MMI to develop a robotic system designed for and with microsurgeons that will improve outcomes and address unmet patient needs, particularly through supermicrosurgery techniques which are required for lymphatic and other extremely delicate procedures. We are pleased to be at the forefront of a new era in robotic surgery as we launch our Symani System in Europe.”
